Intercontinental Exchange, Inc. — Director's Dealing 2025

Aug 14, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Intercontinental Exchange, Inc. (ICE)
CIK: 0001571949
Period of Report: 2025-08-12

Reporting Person: Sprecher Jeffrey C (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-08-12	Common Stock	M	66575	$57.31	Acquired	1229566	Direct
2025-08-12	Common Stock	S	4123	$182.0652	Disposed	1225443	Direct
2025-08-12	Common Stock	S	55252	$182.9487	Disposed	1170191	Direct
2025-08-12	Common Stock	S	2800	$183.9097	Disposed	1167391	Direct
2025-08-12	Common Stock	S	2400	$185.0309	Disposed	1164991	Direct
2025-08-12	Common Stock	S	2000	$185.676	Disposed	1162991	Direct
2025-08-12	Common Stock	S	7900	$181.9877	Disposed	2093805	Indirect
2025-08-12	Common Stock	S	124690	$182.9405	Disposed	1969115	Indirect
2025-08-12	Common Stock	S	7046	$183.7892	Disposed	1962069	Indirect
2025-08-12	Common Stock	S	5443	$185.0006	Disposed	1956626	Indirect
2025-08-12	Common Stock	S	4921	$185.6123	Disposed	1951705	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-08-12	Employee Stock Option (right to buy) Holding	$57.31	M	66575	Disposed	2027-01-18	Common Stock (66575)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	81570	Indirect

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 7, 2024.

F2: Amount of securities beneficially owned includes 83 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2025.

F3: The price range for the aggregate amount sold by the direct holder is $181.54 - $182.53. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F4: The price range for the aggregate amount sold by the direct holder is $182.54 - $183.53. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F5: The price range for the aggregate amount sold by the direct holder is $183.55 - $184.54. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F6: The price range for the aggregate amount sold by the direct holder is $184.55 - $185.54. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F7: The price range for the aggregate amount sold by the direct holder is $185.59 - $185.85. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F8: The common stock number referred in Table I is an aggregate number and represents 1,079,262 shares of common stock, 26,702 unvested restricted stock units ("RSUs"), and 57,027 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.

F9: The satisfaction of the 2023, 2024 and 2025 three-year total shareholder return (TSR) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2026, February 2027 and February 2028, respectively, and will be reported at the time of vesting. The satisfaction of the 2024 and 2025 three-year earnings before interest, taxes, depreciation, and amortization (EBITDA) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027 and February 2028, respectively, and will be reported at the time of vesting.

F10: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.

F11: The price range for the aggregate amount sold by the direct holder is $181.47 - $182.46. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F12: The price range for the aggregate amount sold by the direct holder is $182.49 - $183.48. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F13: The price range for the aggregate amount sold by the direct holder is $183.49 - $184.48. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F14: The price range for the aggregate amount sold by the direct holder is $184.49 - $185.48. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F15: The price range for the aggregate amount sold by the direct holder is $185.50 - $185.85. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F16: As previously reported, the reporting person also indirectly owns 1,951,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.

F17: As previously reported, the reporting person also indirectly owns 81,570 shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.

F18: These options are fully vested.